Skip to main contentSkip to navigation
Sirius Investors
Eastwood Bio-Medical Canada Inc.

Eastwood Bio-Medical Canada Inc.

EWOOF
OTCConsumer Defensive

Eastwood Bio-Medical Canada Inc. (EWOOF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Eastwood Bio-Medical Canada Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2023
P/E Ratio
-292.07
Burn Risk
P/B Ratio
-136.41
Equity Deficit
Earnings Yield
-0.48%
Yield Gap

Profitability Health

2023
Return on Equity
65.01%
Strong
WeakModerateStrong
Operating Margin
-58.21%
Weak
WeakModerateStrong
Net Profit Margin
-62.98%
Weak
WeakModerateStrong

Growth Indicators

2023
Revenue Growth
-33.22%
Weak
WeakModerateStrong
Net Income Growth
-264.69%
Weak
WeakModerateStrong
EPS Growth
-185.00%
Weak
WeakModerateStrong

Efficiency & Liquidity

2023
Current Ratio
0.11
Weak
WeakModerateStrong
Quick Ratio
0.11
Weak
WeakModerateStrong
Asset Turnover
1.77x
Strong
WeakModerateStrong
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2023
Free Cash Flow Yield
-0.01%
Weak
WeakModerateStrong
EV / Free Cash Flow
-6793.95x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.11x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.082
Strong
WeakModerateStrong
Return on Invested Capital
64.87%
Strong
WeakModerateStrong
Cash Conversion Cycle
-81.38 days
Strong
WeakModerateStrong

Fortress screener guardrails

3/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for EWOOF.

View Financial Statements